Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000558127 | SCV000658917 | likely benign | Charcot-Marie-Tooth Neuropathy X | 2023-10-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350395 | SCV002652074 | uncertain significance | Inborn genetic diseases | 2019-12-06 | criteria provided, single submitter | clinical testing | The p.V189I variant (also known as c.565G>A), located in coding exon 1 of the GJB1 gene, results from a G to A substitution at nucleotide position 565. The valine at codon 189 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species, and isoleucine is the reference amino acid in other vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002483509 | SCV002784841 | uncertain significance | Charcot-Marie-Tooth disease X-linked dominant 1 | 2022-04-12 | criteria provided, single submitter | clinical testing | |
Inherited Neuropathy Consortium | RCV000789820 | SCV000929204 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only | ||
Natera, |
RCV000789820 | SCV001462646 | uncertain significance | Charcot-Marie-Tooth disease | 2020-09-16 | no assertion criteria provided | clinical testing |